Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antineoplastic tyrosine kinase inhibitors disclosed by Thomae

Nov. 15, 1996

Promising clinical trial results on Taxotere presented at ESMO meeting

Nov. 15, 1996

First chemotherapeutic drug approved for advanced hormone-refractory prostate cancer

Nov. 15, 1996

First alternative to 5-FU controls disease progression in colorectal cancer

Nov. 15, 1996

Gemzar introduced in Italy

Nov. 15, 1996

Phase II results with DaunoXome in non-Hodgkin's lymphoma

Nov. 15, 1996

Phase I tolerability and safety reported for Agouron's AG-331

Nov. 15, 1996

AltaRex licenses alkylating agent for North America

Nov. 15, 1996

Scotia reports progress on Foscan

Nov. 8, 1996

Scotia's radioprotectant accepted for EMEA review

Nov. 8, 1996